Axceso Biopharma
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $5.1M
Investors
- 5
About Axceso Biopharma
Based in Anyang, South Korea, and founded in 2010, Axceso Biopharma specializes in the development of biopharmaceuticals and a second research center that develops effective therapeutic substances through chemical synthesis., and adopted PHYTOPECIA Hair Tonic as a treatment material for Seoul Asan Hospital in 2011. In 2018, the company changed its name to Axceso Biopharma and signed a research contract with the Korea Biotechnology Research Institute for the development of low-molecular-weight immuno-oncology drugs. The company expanded and relocated its first affiliated research institute followed by the establishment of the second corporate research institute for organic synthesis research in Yongin, Gyeonggi-do in 2019. The company develops and manufactures drugs for the treatment of cancer, neurological diseases, blood infections, diabetes, and Alzheimer's disease.
Who invested in Axceso Biopharma
5 investors across 1 round
See all investors in Axceso Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 1, 2021
Amount
$5.1M
Investors
Questions about Axceso Biopharma
Who invested in Axceso Biopharma?
Axceso Biopharma has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axceso Biopharma raised?
Axceso Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Axceso Biopharma last raise money?
Axceso Biopharma's most recent round on record is a Series A, in Sep 2021.
What does Axceso Biopharma do?
Based in Anyang, South Korea, and founded in 2010, Axceso Biopharma specializes in the development of biopharmaceuticals and a second research center that develops effective therapeutic substances through chemical synthesis.
Where is Axceso Biopharma headquartered?
Axceso Biopharma is headquartered in Anyang, South Korea.
Which VCs invest in companies like Axceso Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Axceso Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Axceso Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.